CN101919987A - Soft capsule for treating vagina - Google Patents
Soft capsule for treating vagina Download PDFInfo
- Publication number
- CN101919987A CN101919987A CN2009100722295A CN200910072229A CN101919987A CN 101919987 A CN101919987 A CN 101919987A CN 2009100722295 A CN2009100722295 A CN 2009100722295A CN 200910072229 A CN200910072229 A CN 200910072229A CN 101919987 A CN101919987 A CN 101919987A
- Authority
- CN
- China
- Prior art keywords
- vagina
- soft capsule
- gram
- treatment
- capsule preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a soft capsule preparation for treating the vagina, which comprises the following components in percentage by weight: 0.1-1% of polyhexamethylene guanide, 1-5% of chitin, 15-25% of oil of zedoary turmeric and balance of soybean oil. The capsule shell formula comprises 200-500g of gelatin, 100-400g of purified water, 50-300g of glycerol, 2-20g of ethylparaben, 2-20g of propylparaben, 20-80g of 9% ethanol and 3-15g of titanium dioxide. The prepared soft capsule can be taken as a product for treating the vagina, and an administration mode of directly pushing the soft capsule into the vagina is adopted. The invention has the characteristics of high effect taking speed, exact treatment effect, short treatment period, simple production process, low cost, safety, no toxicity, wide range of action and the like.
Description
Technical field
The present invention relates to a kind of product of medicine and hygiene fields, be specifically related to a kind of product for the treatment of vagina, relate to the preparation method of this kind product simultaneously.
Background technology
Vaginitis is the inflammation of connective tissue under vaginal mucosa and the mucosa, is the common disease of gynecological's outpatient service.Normal health women, because anatomy and biochemistry characteristics, vagina has the nature defense function to the intrusion of pathogen, when the natural defense function of vagina is destroyed, then pathogen is easy to invade, cause colpitis, youngest daughter and postmenopausal women are owing to estrogen deficiency, and vagina epithelium is poor, the former content of endocellular sugar reduces, vagina PH is up to about 7, and is so vagina is lower for the resistance, easily more infected than the adolescence and the women of child-bearing age.Vaginitis changes with the character of leucorrhea clinically and the pudendum infections is itched, and causalgia is main clinical characters, and sexual anhedonia is also common, infects when involving urethra, and symptoms such as dysurea, urgent micturition can be arranged.
At above symptom, adopt traditional therapeutic modality can not fundamentally treat above disease, content of the present invention uses with polyhexamethylene guanidine, chitin, Oleum Curcumae compatibility, through proportioning screening to prescription, and the softgel shell prescription furtherd investigate, adopt the administering mode that directly pushes vagina, through focus, discharge rapidly, succeeded in developing the prescription of the soft capsule preparation of novel therapeutic vagina.
Summary of the invention
The object of the present invention is to provide a kind of rapid-action, determined curative effect, treatment cycle is short, production process is simple, with low cost, safety non-toxic, the soft capsule preparation that is used for the treatment of vagina that sphere of action is wide.
The present invention realizes by following technical scheme:
The specific embodiment:
Adopting polyhexamethylene guanidine, chitin, Oleum Curcumae is the soft capsule preparation that content is made, its capsule skin constituent is: gelatin, purified water, glycerol, ethyl hydroxybenzoate, propyl p-hydroxybenzoate, 9% ethanol, titanium dioxide, adopt the administering mode that directly pushes vagina, be applied to treat vagina.Its guanidine radicals of hexa-methylene guanidine has very high activity in polyreaction, make polymeric derivative be electropositive, so be easy to be usually electronegative each bacterioid, viral adsorbed, thereby the splitting function that has suppressed antibacterial, virus, make antibacterial, virus lose reproductive function, the thin film of polymer formation has stopped up the respiration channel of microorganism in addition, makes microorganism suffocate the power of losing one's life and reaches sterilization effect.Chitin has the growth that promotes the enteral probiotics, keeps the effect of tract ecological balance, and has very strong antimicrbial power, can improve the function of calcium metabolism and the ability of cellular uptake calcium.Rhizoma Curcumae volatile oil can suppress the growth of staphylococcus aureus, beta hemolytic streptococcus, escherichia coli, Bacillus typhi, vibrio cholera etc.
Experiment showed, polyhexamethylene guanidine, chitin, Oleum Curcumae are used with the proper proportion compatibility, not only can make the complementary expansion of antimicrobial spectrum, also can strengthen fungistatic effect greatly because of its synergism.Adopt the administering mode directly push vagina, through focus, and developed the capsule skin prescription of science, and medicine is discharged rapidly, can regulate the intravaginal environment fast and effectively, thereby reach the purpose of treatment disease.
The present invention has the following advantages:
A, content prescription advanced person use polyhexamethylene guanide, chitin, oil of zedoary turmeric compatibility, have enlarged on the original basis antimicrobial spectrum, and greatly strengthen fungistatic effect because it acts synergistically.
B, capsule skin prescription is advanced, can not only reach quick dissolving, and ethyl hydroxy benzoate and propylparaben also have antisepsis, can effectively prolong shelf life of products.
C, production process are simple to operate, direct fill soft capsule, and technology is controlled easily, and constant product quality.
D, take specialized mode of production science to produce, with short production cycle, low cost of manufacture.
E, environment-friendly type preparation, production process do not use any toxin preparation that has, and no organic reagent is residual.
F, product biological activity are strong, and bactericidal effect is remarkable, does not produce drug resistance.
The present invention is the soft capsule preparation that content is made the novel therapeutic vagina with polyhexamethylene guanidine, chitin, Oleum Curcumae, adopts the administering mode that directly pushes vagina, through focus, and the capsule coupling of science is put the history medicine and is discharged rapidly, and extraordinary clinical efficacy is arranged.And confirm through domestic authoritative expert's demonstration and international medical community, have clear and definite scientific basis and definite curative effect, practical problems such as the medicine antibacterial spectrum was narrow in the past, side effect big, weak effect, pathogenic bacterium generation tolerance have fundamentally been changed, directly push the administering mode of vagina, through focus, and adopted advanced capsule skin prescription, medicine is discharged rapidly, can regulate the intravaginal environment fast and effectively, thereby reach the purpose of treatment disease.Product has characteristics such as fungicidal spectrum is wide, the lasting period is long, biological activity is strong, speed of action is fast, stable in properties, safety non-toxic, through evidence, can effectively kill a series of pathogenic microorganisms such as gold-coloured staphylococci, bacillus subtilis, escherichia coli, Candida albicans, fungus, mycete, virus.And make soft capsule be take into full account the patient easy to use, use rationally, will make this product have more the market competitiveness.
Claims (5)
1. soft capsule preparation that is used for the treatment of vagina.
2. effective ingredient and capsule skin prescription and the administering mode that is used for the treatment of the soft capsule preparation of vagina according to claim 1.
3. the soft capsule preparation that is used for the treatment of vagina according to claim 2 directly pushes vagina, reaches the purpose of treatment disease.
4. according to the described content weight percentage ratio that is used for the treatment of the soft capsule preparation of vagina of claim 1-4 item be: polyhexamethylene guanidine 0.1-1, chitin 1-5, Oleum Curcumae 15-25, soybean oil adds to 100.
5. according to the described prescription that is used for the treatment of the soft capsule preparation of vagina of claim 1-5 item be: gelatin 200-500 gram, purified water 100-400 gram, glycerol 50-300 gram, ethyl hydroxybenzoate 2-20 gram, propyl p-hydroxybenzoate 2-20 gram, 9% ethanol 20-80 gram, titanium dioxide 3-15 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100722295A CN101919987A (en) | 2009-06-09 | 2009-06-09 | Soft capsule for treating vagina |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100722295A CN101919987A (en) | 2009-06-09 | 2009-06-09 | Soft capsule for treating vagina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101919987A true CN101919987A (en) | 2010-12-22 |
Family
ID=43335371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100722295A Pending CN101919987A (en) | 2009-06-09 | 2009-06-09 | Soft capsule for treating vagina |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101919987A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103861035A (en) * | 2014-03-11 | 2014-06-18 | 广州市洋林生物科技开发有限公司 | External composition and external medicine/hygiene product for prevention and treatment of gynecological reproductive tract diseases |
-
2009
- 2009-06-09 CN CN2009100722295A patent/CN101919987A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103861035A (en) * | 2014-03-11 | 2014-06-18 | 广州市洋林生物科技开发有限公司 | External composition and external medicine/hygiene product for prevention and treatment of gynecological reproductive tract diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102028705B (en) | Gynecologic article containing biological antifungal components | |
| CN103083472A (en) | Nano silver anti-inflammatory gel for treating gynecologic inflammation and preparation method thereof | |
| CN103385926A (en) | Antibiosis gel for curing cervical and vaginal diseases of gynaecology | |
| CN101543658B (en) | Cervical cap for preventing and treating cervical erosion and preparation method thereof | |
| CN109288889A (en) | A kind of antibacterial gynecological composition, gel and preparation method thereof | |
| CN109985069A (en) | Probiotic composition and application thereof | |
| CN101797269B (en) | Physiological balance liquid for adjusting microecology in vaginas of women | |
| CN100586441C (en) | Compound sulfamonomethoxine sodium injection and preparation method thereof | |
| CN101829130A (en) | Compound resveratrol anti-inflammatory and itching relieving medicament combination and purpose thereof | |
| CN102038627A (en) | Antibacterial body wash and preparation method thereof | |
| CN107998154B (en) | Probiotics preparation for preventing and treating female diseases and preparation method and application thereof | |
| CN103520262B (en) | A kind of lipid soluble gynecological gel | |
| CN101919987A (en) | Soft capsule for treating vagina | |
| CN103083502A (en) | Drug for treating animal traumatic infection disease | |
| CN1682703A (en) | Sterilizing gel | |
| CN102335462A (en) | Nano iodine-chitosan cervical disease treating membrane agent and preparation method of membrane | |
| CN101612158A (en) | Compound ofloxacin injection of animals for treating postnatal infection and preparation method thereof | |
| CN104523897A (en) | Enteroclysis medicine composition for treating piglet epidemic diarrhea | |
| CN106176916A (en) | A kind of vagina balance conditioning liquid | |
| CN107308104A (en) | A kind of preparation method of gynecological gel | |
| CN105999224A (en) | Bionic gynecological lotion and preparing method thereof | |
| CN101450082B (en) | Vagina disease treatment medicine using biologic live bacteria | |
| CN101757069A (en) | Oral medical liquid for treating chicken mixed infection as well as preparation method and application thereof | |
| CN111632073A (en) | Antibacterial and anti-inflammatory female privates probiotic composition and preparation thereof | |
| CN108904780A (en) | A kind of gynaecological gel and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20101222 |